Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

PRECIOUS-Gold falls, set for worst month in 4 years on vaccine hopes

Published 11/30/2020, 09:15 AM
Updated 11/30/2020, 09:20 AM
© Reuters.
XAU/USD
-
XAG/USD
-
GC
-
SI
-

Nov 30 (Reuters) - Gold slipped on Monday as upbeat equities
fuelled by optimism over a coronavirus vaccine-led economic
rebound offset a weaker dollar, putting the bullion on course
for its worst month in four years.

FUNDAMENTALS
* Spot gold XAU= fell 0.3% to $1,782.72 per ounce by 0049
GMT. U.S. gold futures GCv1 was down 0.1% at $1,778.10.
* Gold is down 5.1% in November, as growing optimism over a
COVID-19 vaccine and greater U.S. political stability under Joe
Biden's incoming administration sparked a sell-off in the metal
and favoured traditionally riskier assets.
* Vaccine optimism and bets for more monetary easing ahead
of testimony in Congress from U.S. Federal Reserve Chairman
Jerome Powell this week, helped to push the dollar to a more
than two-year low and boosted world shares. USD/ MKTS/GLOB
* U.S. health authorities will hold an emergency meeting to
recommend a coronavirus vaccine for healthcare professionals and
people in long-term care facilities, while Britain is set to
approve BioNTech SE 22UAy.DE and Pfizer Inc's PFE.N COVID-19
vaccine. * Although U.S. President Donald Trump pledged to continue
his legal fight to overturn the Nov. 3 election results, his
comments in a Fox News telephone interview suggested he was
growing resigned to his Democratic opponent moving into the
White House on Jan. 20. * Face-to-face negotiations between the UK and the European
Union over a trade deal restarted on Saturday, in a last-ditch
attempt to find agreement with just five weeks to go before
their current relationship ends. * Gold is used as a hedge against inflation, political and
economic uncertainties.
* Physical gold demand in India remained healthy as a drop
in prices to a near five-month low encouraged retail consumers
and jewellers to raise purchases amid wedding season.
* Silver XAG= fell 0.9% to $22.50 per ounce, while
platinum XPT= rose 0.1% to $964.71 and palladium XPD= was up
0.1% at $2,426.31.

DATA/EVENTS (GMT)
1300 Germany Nov. CPI Prelim YY

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.